Gregory Zante
Direttore Finanziario/CFO presso VIKING THERAPEUTICS, INC.
Patrimonio netto: 11 M $ in data 31/05/2024
Profilo
Gregory S.
Zante is currently the Chief Financial Officer at Viking Therapeutics, Inc. He previously held positions as the Director-Finance & Administration at Calyx Therapeutics, Inc., the Senior Vice President at Matrix Pharmaceutical, Inc., the Senior Staff Accountant at Ernst & Young LLP, the Vice President-Finance & Administration at Sangamo Therapeutics, Inc., and the Chief Financial Officer at Aerami Therapeutics, Inc. Mr. Zante obtained his undergraduate degree from the University of California, Los Angeles.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 03/05/2024 | 174 854 ( 0.16% ) | 11 M $ | 31/05/2024 |
Posizioni attive di Gregory Zante
| Società | Posizione | Inizio |
|---|---|---|
| VIKING THERAPEUTICS, INC. | Direttore Finanziario/CFO | 04/01/2021 |
Precedenti posizioni note di Gregory Zante
| Società | Posizione | Fine |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Direttore Amministrativo | 01/06/2013 |
Matrix Pharmaceutical, Inc.
 Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Corporate Officer/Principal | 01/12/2001 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/11/1995 |
Formazione di Gregory Zante
| University of California, Los Angeles | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| VIKING THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Gregory Zante
